http://www.legislation.gov.uk/eur/2016/793/article/5Regulation (EU) 2016/793 of the European Parliament and of the Council of 11 May 2016 to avoid trade diversion into the European Union of certain key medicines (codification)Regulation (EU) 2016/793 of the European Parliament and of the CouncilRegulation (EU) 2016/793 of the European Parliament and of the Council of 11 May 2016 to avoid trade diversion into the European Union of certain key medicines (codification)King's Printer of Acts of Parliamenthttps://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32016R0793texttext/xmlen2024-10-01Expert Participation2023-05-03 Article 51The Secretary of State must from time to time—acarry out a review of this Regulation;bset out the conclusions of the review in a report; andcpublish the report.2The report must in particular—aset out the use of the powers to make regulations at Article 4(3A), Article 4(8), Article 7 and Article 8;bset out any other matters the Secretary of State considers relevant in respect of the powers referred to at paragraph 2(a).3The first report must be published before the end of the period of five years beginning with the date on which the Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 come into force.Art. 5 substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(5)